1
|
Benchaib M, Labrune E, Giscard d'Estaing S, Jovet C, Soignon G, Jaeger P, Salle B. ICSI using testicular spermatozoa after failure of ICSI with ejaculated spermatozoa could be a good choice: A propensity score-matched cohort study. Andrology 2023. [PMID: 38108555 DOI: 10.1111/andr.13572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2022] [Revised: 11/30/2023] [Accepted: 12/02/2023] [Indexed: 12/19/2023]
Abstract
BACKGROUND Ejaculated spermatozoa are considered to possess a higher fertilisation potential than testicular spermatozoa. In selected cases, the use of testicular spermatozoa from non-azoospermic infertile men resulted in a higher implantation and pregnancy rate than the use of ejaculated spermatozoa. OBJECTIVE The primary objective was to compare the live birth rate and cumulative live birth rate between couples with failed intracytoplasmic sperm injection procedure using ejaculated spermatozoa who subsequently had an intracytoplasmic sperm injection cycle with testicular spermatozoa and those who subsequently had an intracytoplasmic sperm injection cycle with ejaculated spermatozoa. The secondary objective was to determine the indications for the use of testicular spermatozoa after intracytoplasmic sperm injection failure with ejaculated spermatozoa. MATERIALS AND METHODS A retrospective study of matched couples using propensity score matching analysis was performed. After an intracytoplasmic sperm injection failure (cycle_1), intracytoplasmic sperm injection with either ejaculated spermatozoa (ejaculated sperm group), or testicular spermatozoa (testicular sperm group), was performed (cycle_2). The matching was on intracytoplasmic sperm injection performed in cycle_1 according to spermatozoa used (testicular or ejaculated) in cycle_2. Logistic regression was used to evaluate the influence of sperm origin on cumulative live birth rate. Univariate analysis on parameters of cycle_1 was used to identify the prognostic factors to propose an intracytoplasmic sperm injection with testicular spermatozoa in case of cycle_1 failure. The study outcomes were live birth rate and cumulative live birth rate. RESULTS Among the 6034 couples available, 63 were selected to constitute the testicular sperm group and 63 were selected by propensity score matching to constitute the ejaculated sperm group. After matching, the DNA fragmentation index was higher in the testicular sperm group (13.43% ± 9.65% vs. 8.93% ± 4.47%, p = 0.013); no significant difference was observed for the fertilisation rate, the number of obtained embryos, blastulation rate and frozen embryo rate. In cycle_2, the live birth rate was higher in the testicular group (22.2% vs. 0.0%, p < 0.001), as was the cumulative live birth rate (25.4% vs. 6.3%, p = 0.065). The prognostic factors identified for the proposal of intracytoplasmic sperm injection procedure with testicular spermatozoa after intracytoplasmic sperm injection failure with ejaculated spermatozoa were: teratozoospermia, cryptozoospermia and high DNA fragmentation index. DISCUSSION According to the present study and current knowledge, the use of testicular spermatozoa after failed intracytoplasmic sperm injection procedure in non-azoospermic men could be proposed instead of sperm donation in case of high sperm DNA fragmentation index, cryptozoospermia and teratozoospermia. A good oocyte response to ovarian stimulation during the previous assisted reproductive technology attempt will increase the chance of success. Although the main limitation of the current study is its retrospective nature, the use of the propensity score matching to perform causal inference study increases its reliability. CONCLUSION The present study supports that the use of testicular spermatozoa outside the classical indication of azoospermia is a good option when the indication is well established. However, before proposing a testicular biopsy, an improvement in sperm characteristics should be considered by treating the causes of sperm alteration.
Collapse
Affiliation(s)
- Mehdi Benchaib
- Hospices Civils de Lyon, HFME, Biologie de la Reproduction, Cedex Bron, France
- UMR CNRS 5558, LBBE, Villeurbanne Cedex, France
- Faculté de Médecine Lyon Est, Université Claude Bernard, Lyon, France
| | - Elsa Labrune
- Hospices Civils de Lyon, HFME, Biologie de la Reproduction, Cedex Bron, France
- Faculté de Médecine Lyon Est, Université Claude Bernard, Lyon, France
- Inserm U1208, Bron Cedex, France
| | - Sandrine Giscard d'Estaing
- Hospices Civils de Lyon, HFME, Biologie de la Reproduction, Cedex Bron, France
- Inserm U1208, Bron Cedex, France
- Faculté de Médecine Lyon Sud, Université Claude Bernard, Oullins Cedex, France
| | - Cynthia Jovet
- Hospices Civils de Lyon, HFME, Biologie de la Reproduction, Cedex Bron, France
- Faculté de Médecine Lyon Est, Université Claude Bernard, Lyon, France
| | - Gaëlle Soignon
- Hospices Civils de Lyon, HFME, Biologie de la Reproduction, Cedex Bron, France
| | - Pauline Jaeger
- Hospices Civils de Lyon, HFME, Biologie de la Reproduction, Cedex Bron, France
| | - Bruno Salle
- Hospices Civils de Lyon, HFME, Biologie de la Reproduction, Cedex Bron, France
- Inserm U1208, Bron Cedex, France
- Faculté de Médecine Lyon Sud, Université Claude Bernard, Oullins Cedex, France
| |
Collapse
|
2
|
Feraille A, Liard A, Rives N, Bubenheim M, Barbotin AL, Giscard d'Estaing S, Mirallié S, Ancelle A, Roux C, Brugnon F, Daudin M, Schneider P, Dumont L, Rondanino C. Impact of low- or moderate-risk gonadotoxic chemotherapy prior to testicular tissue freezing on spermatogonia quantity in human (pre)pubertal testicular tissue. Hum Reprod 2023; 38:2105-2118. [PMID: 37674325 DOI: 10.1093/humrep/dead161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2022] [Revised: 06/20/2023] [Indexed: 09/08/2023] Open
Abstract
STUDY QUESTION What is the impact of low- or moderate-risk gonadotoxic chemotherapy received prior to testicular tissue freezing (TTF), and of the cancer itself, on spermatogonia quantity in testicular tissue from (pre)pubertal boys? SUMMARY ANSWER Vincristine, when associated with alkylating agents, has an additional adverse effect on spermatogonia quantity, while carboplatin has no individual contribution to spermatogonia quantity, in testicular tissue of (pre)pubertal boys, when compared to patients who have received non-alkylating chemotherapy. WHAT IS KNOWN ALREADY The improved survival rates after cancer treatment necessitate the inclusion of fertility preservation procedures as part of the comprehensive care for patients, taking into consideration their age. Sperm cryopreservation is an established procedure in post-pubertal males while the TTF proposed for (pre)pubertal boys remains experimental. Several studies exploring testicular tissue of (pre)pubertal boys after TTF have examined the tubular fertility index (TFI, percentage of seminiferous tubule cross-sections containing spermatogonia) and the number of spermatogonia per seminiferous tubule cross-section (S/T). All studies have demonstrated that TFI and S/T always decrease after the introduction of chemotherapeutic agents, especially those which carry high gonadotoxic risks such as alkylating agents. STUDY DESIGN, SIZE, DURATION Testicular tissue samples from 79 (pre)pubertal boys diagnosed with cancer (from 6 months to 16 years of age) were cryopreserved between May 2009 and June 2014. Their medical diagnoses and previous chemotherapy exposures were recorded. We examined histological sections of (pre)pubertal testicular tissue to elucidate whether the chemotherapy or the primary diagnosis affects mainly TFI and S/T. PARTICIPANTS/MATERIALS, SETTING, METHODS (Pre)pubertal boys with cancer diagnosis who had been offered TTF prior to conditioning treatment for hematopoietic stem cell transplantation were included in the study. All the patients had previously received chemotherapy with low- or moderate-risk for future fertility. We have selected patients for whom the information on the chemotherapy received was complete. The quantity of spermatogonia and quality of testicular tissue were assessed by both morphological and immunohistochemical analyses. MAIN RESULTS AND THE ROLE OF CHANCE A significant reduction in the number of spermatogonia was observed in boys treated with alkylating agents. The mean S/T values in boys exposed to alkylating agents were significantly lower compared to boys exposed to non-alkylating agents (P = 0.018). In contrast, no difference was observed for patients treated with carboplatin as the sole administered alkylating agent compared to the group of patients exposed to non-alkylating agents. We observed an increase of S/T with age in the group of patients who did not receive any alkylating agent and a decrease of S/T with age when patients received alkylating agents included in the cyclophosphamide equivalent dose (CED) formula (r = 0.6166, P = 0.0434; r = -0.3759, P = 0.0036, respectively). The TFI and S/T decreased further in the group of patients who received vincristine in combination with alkylating agents (decrease of 22.4%, P = 0.0049 and P < 0.0001, respectively), but in this group the CED was also increased significantly (P < 0.0001). Multivariate analysis, after CED adjustment, showed the persistence of a decrease in TFI correlated with vincristine administration (P = 0.02). LIMITATIONS, REASONS FOR CAUTION This is a descriptive study of testicular tissues obtained from (pre)pubertal boys who were at risk of infertility. The study population is quite heterogeneous, with a small number of patients in each sub-group. Our results are based on comparisons between patients receiving alkylating agents compared to patients receiving non-alkylating agents rather than chemotherapy-naive patients. The French national guidelines for fertility preservation in cancer patients recommend TTF before highly gonadotoxic treatment. Therefore, all the patients had received low- or moderate-risk gonadotoxic chemotherapy before TTF. Access to testicular tissue samples from chemotherapy-naive patients with comparable histological types of cancer was not possible. The functionality of spermatogonia and somatic cells could not be tested by transplantation or in vitro maturation due to limited sample sizes. WIDER IMPLICATIONS OF THE FINDINGS This study summarizes the spermatogonial quantity of (pre)pubertal boys prior to TTF. We confirmed a negative correlation between the cumulative exposure to alkylating agents and spermatogonial quantity. In addition, the synergistic use of vincristine in combination with alkylating agents showed a cumulative deleterious effect on the TFI. For patients for whom fertility preservation is indicated, TTF should be proposed for chemotherapy with a predicted CED above 4000 mg/m2. However, the data obtained from vincristine and carboplatin use should be confirmed in a subsequent study including more patients. STUDY FUNDING/COMPETING INTEREST(S) This study had financial support from a French national research grant PHRC No. 2008/071/HP obtained by the French Institute of Cancer and the French Healthcare Organization. The sponsors played no role in the study. The authors declare no conflicts of interest. TRIAL REGISTRATION NUMBER N/A.
Collapse
Affiliation(s)
- Aurélie Feraille
- Biology of Reproduction-CECOS Laboratory, Univ Rouen Normandie, Inserm U1239, NorDIC, Team "Adrenal and Gonadal Pathophysiology", Rouen University Hospital, Rouen, France
| | - Agnès Liard
- Department of Child Surgery, Univ Rouen Normandie, Rouen University Hospital, Rouen, France
| | - Nathalie Rives
- Biology of Reproduction-CECOS Laboratory, Univ Rouen Normandie, Inserm U1239, NorDIC, Team "Adrenal and Gonadal Pathophysiology", Rouen University Hospital, Rouen, France
| | | | - Anne-Laure Barbotin
- Institut de Biologie de la Reproduction-Spermiologie-CECOS de Lille, CHU de Lille, Lille, France
| | | | - Sophie Mirallié
- Laboratoire de Biologie de la Reproduction-CECOS de Nantes, CHU de Nantes, Nantes, France
| | - Amélie Ancelle
- Laboratoire de Biologie de la Reproduction-CECOS de Caen, CHU de Caen, Caen, France
| | - Christophe Roux
- Laboratoire de Biologie de la Reproduction-CECOS de Besançon, CHU de Besançon, Besançon, France
| | - Florence Brugnon
- Laboratoire de Biologie de la Reproduction-CECOS d'Auvergne, CHU de Clermont-Ferrand, Clermont-Ferrand, France
| | - Myriam Daudin
- CECOS Midi-Pyrénées, University Hospital of Toulouse, Hôpital Paule de Viguier, Toulouse, France
| | - Pascale Schneider
- Department of Pediatric Hematology and Oncology, Univ Rouen Normandie, Rouen University Hospital, Rouen, France
| | - Ludovic Dumont
- Biology of Reproduction-CECOS Laboratory, Univ Rouen Normandie, Inserm U1239, NorDIC, Team "Adrenal and Gonadal Pathophysiology", Rouen University Hospital, Rouen, France
| | - Christine Rondanino
- Biology of Reproduction-CECOS Laboratory, Univ Rouen Normandie, Inserm U1239, NorDIC, Team "Adrenal and Gonadal Pathophysiology", Rouen University Hospital, Rouen, France
| |
Collapse
|
3
|
Guth M, Coste A, Lefevre M, Deygas F, Danjou A, Ahmadi S, Dananché B, Pérol O, Boyle H, Schüz J, Bujan L, Metzler-Guillemain C, Giscard d'Estaing S, Teletin M, Ducrocq B, Frapsauce C, Olsson A, Charbotel B, Fervers B. Testicular germ cell tumour risk by occupation and industry: a French case-control study - TESTIS. Occup Environ Med 2023; 80:407-417. [PMID: 37230752 PMCID: PMC10314033 DOI: 10.1136/oemed-2022-108601] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2022] [Accepted: 05/04/2023] [Indexed: 05/27/2023]
Abstract
OBJECTIVE Testicular germ cell tumours (TGCT) are the most common cancer in men of working age and its incidence has increased notably over the past 40 years. Several occupations have been identified as potentially associated with TGCT risk. The aim of this study was to further explore the relationship between occupations, industries and TGCT risk in men aged 18-45 years. METHODS The TESTIS study is a multicenter case-control study conducted between January 2015 and April 2018 in 20 of 23 university hospital centers in metropolitan France. A total of 454 TGCT cases and 670 controls were included. Full job histories were collected. Occupations were coded according to the International Standard Classification of Occupation 1968 version (ISCO-1968) and industry according to the 1999 version of Nomenclature d'Activités Française (NAF-1999). For each job held, ORs and 95% CIs were estimated using conditional logistic regression. RESULTS A positive association was observed between TGCT and occupation as agricultural, animal husbandry worker (ISCO: 6-2; OR 1.71; 95% CI (1.02 to 2.82)), as well as salesman (ISCO: 4-51; OR 1.84; 95% CI (1.20 to 2.82)). An increased risk was further observed among electrical fitters and related, electrical and electronics workers employed for 2 years or more (ISCO: 8-5; OR≥2 years 1.83; 95% CI (1.01 to 3.32)). Analyses by industry supported these findings. CONCLUSIONS Our findings suggest that agricultural, electrical and electronics workers, and salesmen workers experience an increased risk of TGCT. Further research is needed to identify the agents or chemicals in these high-risk occupations which are relevant in the TGCT development. TRIAL REGISTRATION NUMBER NCT02109926.
Collapse
Affiliation(s)
- Margot Guth
- UMRESTTE, Université Claude Bernard Lyon 1, Lyon, France
| | - Astrid Coste
- Radiation: Defense, Health, Environment, INSERM UMR1296, Lyon, France
- Prevention Cancer Environnement Departement, Centre Léon Bérard, Lyon, France
| | - Marie Lefevre
- UMRESTTE, Université Claude Bernard Lyon 1, Lyon, France
| | | | - Aurélie Danjou
- Environment and Lifestyle Epidemiology Branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France
| | - Shukrullah Ahmadi
- Environment and Lifestyle Epidemiology Branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France
| | - Brigitte Dananché
- Prevention Cancer Environnement Departement, Centre Léon Bérard, Lyon, France
| | - Olivia Pérol
- Prevention Cancer Environnement Departement, Centre Léon Bérard, Lyon, France
| | - Helen Boyle
- Department of Medical Oncology, Centre Léon Bérard, Lyon, France
| | - Joachim Schüz
- Environment and Lifestyle Epidemiology Branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France
| | - Louis Bujan
- DEFE (Développement Embryonnaire, Fertilité, Environnement) INSERM 1202 Universités Montpellier et Toulouse 3, CECOS Hôpital Paule de Viguier, CHU de Toulouse, Toulouse, France
- Fédération Française des CECOS, Paris, France
| | - Catherine Metzler-Guillemain
- Fédération Française des CECOS, Paris, France
- Centre Clinico-Biologique d'AMP-CECOS, AP-HM La Conception University Hospital, Marseille, France
| | - Sandrine Giscard d'Estaing
- Fédération Française des CECOS, Paris, France
- CECOS de Lyon, Service de Médecine de la Reproduction, Hôpital Femme Mère Enfant, Bron, France
| | - Marius Teletin
- Fédération Française des CECOS, Paris, France
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch-Grafenstaden, France
| | - Berengere Ducrocq
- Fédération Française des CECOS, Paris, France
- CECOS Nord Lille, Hôpital Albert Calmette, Lille, France
| | - Cynthia Frapsauce
- Fédération Française des CECOS, Paris, France
- Médecine et Biologie de la Reproduction-CECOS, CHU Bretonneau, Tours, France
| | - Ann Olsson
- Environment and Lifestyle Epidemiology Branch, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France
| | - Barbara Charbotel
- UMRESTTE, Université Claude Bernard Lyon 1, Lyon, France
- Service des Maladies Professionnelles, Hospices Civils de Lyon, Pierre Bénite, France
| | - Béatrice Fervers
- Radiation: Defense, Health, Environment, INSERM UMR1296, Lyon, France
- Prevention Cancer Environnement Departement, Centre Léon Bérard, Lyon, France
| |
Collapse
|
4
|
Rives N, Courbière B, Almont T, Kassab D, Berger C, Grynberg M, Papaxanthos A, Decanter C, Elefant E, Dhedin N, Barraud-Lange V, Béranger MC, Demoor-Goldschmidt C, Frédérique N, Bergère M, Gabrel L, Duperray M, Vermel C, Hoog-Labouret N, Pibarot M, Provansal M, Quéro L, Lejeune H, Methorst C, Saias J, Véronique-Baudin J, Giscard d'Estaing S, Farsi F, Poirot C, Huyghe É. What should be done in terms of fertility preservation for patients with cancer? The French 2021 guidelines. Eur J Cancer 2022; 173:146-166. [PMID: 35932626 DOI: 10.1016/j.ejca.2022.05.013] [Citation(s) in RCA: 20] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2022] [Revised: 05/02/2022] [Accepted: 05/12/2022] [Indexed: 11/03/2022]
Abstract
AIM To provide practice guidelines about fertility preservation (FP) in oncology. METHODS We selected 400 articles after a PubMed review of the literature (1987-2019). RECOMMENDATIONS Any child, adolescent and adult of reproductive age should be informed about the risk of treatment gonadotoxicity. In women, systematically proposed FP counselling between 15 and 38 years of age in case of treatment including bifunctional alkylating agents, above 6 g/m2 cyclophosphamide equivalent dose (CED), and for radiation doses on the ovaries ≥3 Gy. For postmenarchal patients, oocyte cryopreservation after ovarian stimulation is the first-line FP technique. Ovarian tissue cryopreservation should be discussed as a first-line approach in case of treatment with a high gonadotoxic risk, when chemotherapy has already started and in urgent cases. Ovarian transposition is to be discussed prior to pelvic radiotherapy involving a high risk of premature ovarian failure. For prepubertal girls, ovarian tissue cryopreservation should be proposed in the case of treatment with a high gonadotoxic risk. In pubertal males, sperm cryopreservation must be systematically offered to any male who is to undergo cancer treatment, regardless of toxicity. Testicular tissue cryopreservation must be proposed in males unable to cryopreserve sperm who are to undergo a treatment with intermediate or severe risk of gonadotoxicity. In prepubertal boys, testicular tissue preservation is: - recommended for chemotherapy with a CED ≥7500 mg/m2 or radiotherapy ≥3 Gy on both testicles. - proposed for chemotherapy with a CED ≥5.000 mg/m2 or radiotherapy ≥2 Gy. If several possible strategies, the ultimate choice is made by the patient.
Collapse
Affiliation(s)
- Nathalie Rives
- Normandie Univ, UNIROUEN, Team "Adrenal and Gonadal Physiopathology" Inserm U1239 Nordic, Rouen University Hospital, Biology of Reproduction-CECOS Laboratory, Rouen, France
| | - Blandine Courbière
- Reproductive Medicine and Biology Department, Assistance Publique Hôpitaux de Marseille, Marseille, Provence-Alpes-Côte d'Azur, France
| | - Thierry Almont
- Cancerology, Urology, Hematology Department, Centre Hospitalier Universitaire de Martinique, Fort-de-France, Martinique, France; General Cancer Registry of Martinique UF1441, Centre Hospitalier Universitaire de Martinique, Fort-de-France, Martinique, France
| | - Diana Kassab
- Methodology Unit, Association Française d'Urologie, Paris, Ile-de-France, France
| | - Claire Berger
- Department of Pediatric Hematology and Oncology, University-Hospital of Saint-Etienne, Hospital, Nord Saint-Etienne cedex 02, France 42055; Childhood Cancer Registry of the Rhône-Alpes Region, University of Saint-Etienne, 15 rue Ambroise Paré, Saint-Etienne cedex 02, France 42023
| | - Michaël Grynberg
- Reproductive Medicine and Fertility Department, Hôpital Antoine-Beclère, Clamart, Île-de-France, France
| | - Aline Papaxanthos
- Reproductive Medicine and Biology Department, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, Aquitaine, France
| | - Christine Decanter
- Medically Assisted Procreation and Fertility Preservation Department, Centre Hospitalier Régional Universitaire de Lille, Lille, Hauts-de-France, France
| | - Elisabeth Elefant
- Reference Center for Teratogenic Agents, Hôpital Armand-Trousseau Centre de Référence sur les Agents Tératogènes, Paris, Île-de-France, France
| | - Nathalie Dhedin
- Adolescents and Young Adults Unit, Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris, France
| | - Virginie Barraud-Lange
- Reproductive Medicine and Biology Department, Hôpital Cochin, Paris, Île-de-France, France
| | | | | | - Nicollet Frédérique
- Information and Promotion Department, Association Laurette Fugain, Paris, France
| | - Marianne Bergère
- Human Reproduction, Embryology and Genetics Directorate, Agence de la biomédecine, La Plaine Saint-Denis, France
| | - Lydie Gabrel
- Good Practices Unit - Guidelines and Medicines Directorate, Institut National du Cancer, Billancourt, Île-de-France, France
| | - Marianne Duperray
- Guidelines and Drug Directorate, Institut National du Cancer, Billancourt, Île-de-France, France
| | - Christine Vermel
- Expertise Quality and Compliance Mission - Communication and Information Directorate, Institut National du Cancer, Billancourt, Île-de-France, France
| | - Natalie Hoog-Labouret
- Research and Innovation, Institut National du Cancer, Billancourt, Île-de-France, France
| | - Michèle Pibarot
- OncoPaca-Corse Regional Cancer Network, Assistance Publique - Hôpitaux de Marseille, Marseille, Provence-Alpes-Côte d'Azur, France
| | - Magali Provansal
- Medical Oncology Department, Institut Paoli-Calmettes, Marseille, Provence-Alpes-Côte d'Azur, France
| | - Laurent Quéro
- Cancerology and Radiotherapy Department, Hôpital Saint Louis, AP-HP, Paris, France
| | - Hervé Lejeune
- Reproductive Medicine and Biology Department, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France
| | - Charlotte Methorst
- Reproductive Medicine and Biology Department, Centre Hospitalier des Quatre Villes - Site de Saint-Cloud, Saint-Cloud, France
| | - Jacqueline Saias
- Reproductive Medicine and Biology Department, Assistance Publique Hôpitaux de Marseille, Marseille, Provence-Alpes-Côte d'Azur, France
| | - Jacqueline Véronique-Baudin
- Cancerology, Urology, Hematology Department, Centre Hospitalier Universitaire de Martinique, Fort-de-France, Martinique, France; General Cancer Registry of Martinique UF1441, Centre Hospitalier Universitaire de Martinique, Fort-de-France, Martinique, France
| | - Sandrine Giscard d'Estaing
- Reproductive Medicine and Biology Department, Hospices Civils de Lyon, Lyon, Auvergne-Rhône-Alpes, France
| | - Fadila Farsi
- Regional Cancer Network, Réseau Espace Santé Cancer, Lyon, Rhône-Alpes, France
| | - Catherine Poirot
- Adolescents and Young Adults Unit, Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris, France
| | - Éric Huyghe
- Urology Department, Centre Hospitalier Universitaire de Toulouse, Toulouse, France; Laboratoire Développement Embryonnaire, Fertilité et Environnement (DEFE) UMR 1203, Université Toulouse 3 Paul Sabatier, Toulouse, France.
| |
Collapse
|
5
|
Benchaib M, Labrune E, Giscard d'Estaing S, Salle B, Lornage J. Shallow artificial networks with morphokinetic time‐lapse parameters coupled to
ART
data allow to predict live birth. Reprod Med Biol 2022; 21:e12486. [PMID: 36310657 PMCID: PMC9601773 DOI: 10.1002/rmb2.12486] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2022] [Revised: 08/10/2022] [Accepted: 09/08/2022] [Indexed: 12/02/2022] Open
Abstract
Purpose The purpose of this work was to construct shallow neural networks (SNN) using time‐lapse technology (TLT) from morphokinetic parameters coupled to assisted reproductive technology (ART) parameters in order to assist the choice of embryo(s) to be transferred with the highest probability of achieving a live birth (LB). Methods A retrospective observational single‐center study was performed, 654 cycles were included. Three SNN: multilayers perceptron (MLP), simple recurrent neuronal network (simple RNN) and long short term memory RNN (LSTM‐RNN) were trained with K‐fold cross‐validation to avoid sampling bias. The predictive power of SNNs was measured using performance scores as AUC (area under curve), accuracy, precision, Recall and F1 score. Results In the training data group, MLP and simple RNN provide the best performance scores; however, all AUCs were above 0.8. In the validating data group, all networks were equivalent with no performance scores difference and all AUC values were above 0.8. Conclusion Coupling morphokinetic parameters with ART parameters allows to SNNs to predict the probability of LB, and all SNNs seems to be efficient according to the performance scores. An automatic time recognition system coupled to one of these SNNs could allow a complete automation to choose the blastocyst(s) to be transferred.
Collapse
Affiliation(s)
- Mehdi Benchaib
- Hospices Civil de Lyon, HFME, Médecine de la Reproduction & Préservation de la Fertilité Féminine Bron cedex France
- UMR CNRS 5558 LBBE Villeurbanne Cedex France
- Université Lyon I, Faculté de Médecine Lyon Est Lyon France
| | - Elsa Labrune
- Hospices Civil de Lyon, HFME, Médecine de la Reproduction & Préservation de la Fertilité Féminine Bron cedex France
- Université Lyon I, Faculté de Médecine Lyon Est Lyon France
- Inserm U1208 Bron cedex France
| | - Sandrine Giscard d'Estaing
- Hospices Civil de Lyon, HFME, Médecine de la Reproduction & Préservation de la Fertilité Féminine Bron cedex France
- Inserm U1208 Bron cedex France
- Université Lyon I, Faculté de Médecine Lyon Sud Oullins cedex France
| | - Bruno Salle
- Hospices Civil de Lyon, HFME, Médecine de la Reproduction & Préservation de la Fertilité Féminine Bron cedex France
- Inserm U1208 Bron cedex France
- Université Lyon I, Faculté de Médecine Lyon Sud Oullins cedex France
| | - Jacqueline Lornage
- Hospices Civil de Lyon, HFME, Médecine de la Reproduction & Préservation de la Fertilité Féminine Bron cedex France
- Inserm U1208 Bron cedex France
- Université Lyon I, Faculté de Médecine Lyon Sud Oullins cedex France
| |
Collapse
|
6
|
Rives-Feraille A, Liard A, Bubenheim M, Barbotin AL, Giscard d'Estaing S, Mirallié S, Ancelle A, Roux C, Brugnon F, Grèze V, Daudin M, Willson-Plat G, Dubois R, Sibert L, Schneider P, Rives N. Assessment of the architecture and integrity of frozen-thawed testicular tissue from (pre)pubertal boys with cancer. Andrology 2021; 10:279-290. [PMID: 34628730 DOI: 10.1111/andr.13116] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2021] [Revised: 09/09/2021] [Accepted: 09/29/2021] [Indexed: 01/14/2023]
Abstract
BACKGROUND Testicular tissue freezing is proposed for fertility preservation to (pre)pubertal boys with cancer before highly gonadotoxic treatment. Studies accurately comparing human (pre)pubertal testicular tissue quality before freezing and after thawing are exceptional. No study has reported this approach in a systematic manner and routine care. OBJECTIVES To assess the impact of a control slow freezing protocol on testicular tissue architecture and integrity of (pre)pubertal boys after thawing. MATERIALS AND METHODS (Pre)pubertal boys (n = 87) with cancer from 8 Reproductive Biology Laboratories of the French CECOS network benefited from testicular tissue freezing before hematopoietic stem cell transplantation. Seminiferous tubule cryodamage was determined histologically by scoring morphological alterations and by quantifying intratubular spermatogonia and the expression of DNA replication and repair marker in frozen-thawed testicular fragments. RESULTS A significant increase in nuclear and epithelial score alterations was observed after thawing (p < 0.0001). The global lesional score remained lower than 1.5 and comparable to fresh testicular tissue. The number of intratubular spermatogonia and the expression of DNA replication and repair marker in spermatogonia and Sertoli cells did not vary significantly after thawing. These data showed the good preservation of the seminiferous tubule integrity and architecture after thawing, as previously reported in our studies performed in prepubertal mice and rats. DISCUSSION The current study reports, for the first time, the development of a semi-quantitative analysis of cryodamage in human (pre)pubertal testicular tissue, using a rapid and useful tool that can be proposed in routine care to develop an internal and external quality control for testicular tissue freezing. This tool can also be used when changing one or several parameters of the freezing-thawing procedure. CONCLUSION Control slow freezing protocol without seeding maintains the seminiferous tubule architecture and integrity, the concentration of spermatogonia and the expression of DNA replication and repair marker in spermatogonia and Sertoli cells after thawing.
Collapse
Affiliation(s)
- Aurélie Rives-Feraille
- Normandie Univ, UNIROUEN, EA 4308 "Gametogenesis and Gamete Quality", Rouen University Hospital, Biology of Reproduction-CECOS Laboratory, Rouen, France
| | - Agnès Liard
- Normandie Univ, UNIROUEN, Rouen University Hospital, Department of Child Surgery, Rouen, France
| | | | - Anne Laure Barbotin
- Institut de Biologie de la Reproduction - Spermiologie - CECOS de Lille, CHU de Lille, Lille, France
| | | | - Sophie Mirallié
- Laboratoire de Biologie de la Reproduction - CECOS de Nantes, CHU de Nantes, Rouen, France
| | - Amélie Ancelle
- Laboratoire de Biologie de la Reproduction - CECOS de Caen, CHU de Caen, Rouen, France
| | - Christophe Roux
- Laboratoire de Biologie de la Reproduction - CECOS de Besançon, CHU de Besançon, Rouen, France
| | - Florence Brugnon
- Laboratoire de Biologie de la Reproduction - CECOS d'Auvergne, CHU de Clermont-Ferrand, Rouen, France
| | - Victoria Grèze
- Service d'Hématologie Oncologie Pédiatrique, CHU de Clermont-Ferrand, Rouen, France
| | - Myriam Daudin
- CECOS Midi-Pyrénées, University Hospital of Toulouse, Hôpital Paule de Viguier, Rouen, France
| | - Geneviève Willson-Plat
- Service d'Hématologie Oncologie Pédiatrique, University Hospital of Toulouse, Hôpital des Enfants, Rouen, France
| | - Rémi Dubois
- Département de Chirurgie Pédiatrique viscérale, CHU de Lyon, Rouen, France
| | - Louis Sibert
- Normandie Univ, UNIROUEN, Rouen University Hospital, Department of Urology and Andrology, Rouen, France
| | - Pascale Schneider
- Normandie Univ, UNIROUEN, Rouen University Hospital, Department of Pediatric Hematology and Oncology, Rouen, France
| | - Nathalie Rives
- Normandie Univ, UNIROUEN, EA 4308 "Gametogenesis and Gamete Quality", Rouen University Hospital, Biology of Reproduction-CECOS Laboratory, Rouen, France
| |
Collapse
|
7
|
Giscard d'Estaing S, Labrune E, Forcellini M, Edel C, Salle B, Lornage J, Benchaib M. A machine learning system with reinforcement capacity for predicting the fate of an ART embryo. Syst Biol Reprod Med 2021; 67:64-78. [PMID: 33719832 DOI: 10.1080/19396368.2020.1822953] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
The aim of this work was to construct a score issued from a machine learning system with self-improvement capacity able to predict the fate of an ART embryo incubated in a time lapse monitoring (TLM) system. A retrospective study was performed. For the training data group, 110 couples were included and, 891 embryos were cultured. For the global setting data group, 201 couples were included, and 1186 embryos were cultured. No image analysis was used; morphokinetic parameters from the first three days of embryo culture were used to perform a logistic regression between the cell number and time. A score named DynScore was constructed, the prediction power of the DynScore on blastocyst formation and the baby delivery were tested via the area under the curve (AUC) obtained from the receiver operating characteristic (ROC). In the training data group, the DynScore allowed the blastocyst formation prediction (AUC = 0.634, p < 0.001), this approach was the higher among the set of the tested scores. Similar results were found with the global setting data group (AUC = 0.638, p < 0.001) and it was possible to increase the AUC of the DynScore with a regular update of the prediction system by reinforcement, with an AUC able to reach a value above 0.9. As only the best blastocysts were transferred, none of the tested scores was able to predict delivery. In conclusion, the DynScore seems to be able to predict the fate of an embryo. The reinforcement of the prediction system allows maintaining the predictive capacity of DynScore irrespective of the various events that may occur during the ART process. The DynScore could be implemented in any TLM system and adapted by itself to the data of any ART center.Abbreviations: ART: assisted reproduction technology; TLM: time lapse monitoring system; AUC: area under the curve; ROC: receiver operating characteristic; eSET: elective single embryo transfer; AIS: artificial intelligence system; KID: known implantation data; AMH: anti-Müllerian hormone; BMI: body mass index; WHO: World Health Organization; c-IVF: conventional in-vitro fertilization; ICSI: intracytoplasmic sperm injection; PNf: pronuclear formation; D3: day 3; D5: day 5; D6: day 6; GnRH: gonadotrophin releasing hormone; FSH: follicle stimulating hormone; LH: luteinizing hormone; hCG: human chorionic gonadotropin; PVP: polyvinyl pyrrolidone; PNf: time of pronuclear fading; tx: time of cleavage to x blastomeres embryo; ICM: inner cell mass; TE: trophectoderm; NbCellt: number of cells at t time; FIFO: first in first out; TD: training data group; SD: setting data group; R: real world.
Collapse
Affiliation(s)
- Sandrine Giscard d'Estaing
- Biologie de la Reproduction, Hospices Civil de Lyon, HFME, Bron, France.,Inserm U1208, Bron, France.,Faculté de Médecine Lyon Sud, Université Claude Bernard, Oullins, France
| | - Elsa Labrune
- Biologie de la Reproduction, Hospices Civil de Lyon, HFME, Bron, France.,Inserm U1208, Bron, France.,Faculté de Médecine Lyon Est, Université Claude Bernard, Lyon, France
| | | | - Cecile Edel
- Biologie de la Reproduction, Hospices Civil de Lyon, HFME, Bron, France.,Faculté de Médecine Lyon Sud, Université Claude Bernard, Oullins, France
| | - Bruno Salle
- Biologie de la Reproduction, Hospices Civil de Lyon, HFME, Bron, France.,Inserm U1208, Bron, France.,Faculté de Médecine Lyon Sud, Université Claude Bernard, Oullins, France
| | - Jacqueline Lornage
- Biologie de la Reproduction, Hospices Civil de Lyon, HFME, Bron, France.,Inserm U1208, Bron, France.,Faculté de Médecine Lyon Sud, Université Claude Bernard, Oullins, France
| | - Mehdi Benchaib
- Biologie de la Reproduction, Hospices Civil de Lyon, HFME, Bron, France.,Inserm U1208, Bron, France.,Faculté de Médecine Lyon Est, Université Claude Bernard, Lyon, France.,Riverly, IRSTEA, Villeurbanne, France
| |
Collapse
|
8
|
Nicolini FE, Alcazer V, Huguet F, Cony-Makhoul P, Heiblig M, Fort MP, Morisset S, Guerci-Bresler A, Soula V, Sobh M, d'Estaing SG, Daudin M, Etienne G. CML patients show sperm alterations at diagnosis that are not improved with imatinib treatment. Leuk Res 2016; 48:80-3. [PMID: 27501271 DOI: 10.1016/j.leukres.2016.07.008] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2016] [Revised: 07/12/2016] [Accepted: 07/21/2016] [Indexed: 10/21/2022]
Affiliation(s)
- Franck-Emmanuel Nicolini
- Hematology Department 1G, Centre Hospitalier Lyon Sud, Pierre Bénite, France; INSERM U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France; French Group of CML (Fi-LMC Group), Bordeaux, France.
| | - Vincent Alcazer
- Hematology Department 1G, Centre Hospitalier Lyon Sud, Pierre Bénite, France
| | - Françoise Huguet
- Hematology Department, Hôpital Purpan, Toulouse, France; French Group of CML (Fi-LMC Group), Bordeaux, France
| | - Pascale Cony-Makhoul
- Hematology Department, Centre Hospitalier d'Annecy-Genevois, Metz-Tessy, France; French group of CML (Fi-LMC group), Bordeaux, France
| | - Mael Heiblig
- Hematology Department 1G, Centre Hospitalier Lyon Sud, Pierre Bénite, France
| | | | - Stéphane Morisset
- Hematology Department 1G, Centre Hospitalier Lyon Sud, Pierre Bénite, France
| | - Agnès Guerci-Bresler
- Hematology Department, Hôpital de Brabois, Vandoeuvre-lès-Nancy, France; French Group of CML (Fi-LMC Group), Bordeaux, France
| | - Volcy Soula
- CECOS & service de biologie de la reproduction, Hôpital Pellegrin, Bordeaux, France
| | - Mohamad Sobh
- Hematology Department 1G, Centre Hospitalier Lyon Sud, Pierre Bénite, France
| | | | - Myriam Daudin
- CECOS, Groupe d'Activité de Médecine de la Reproduction, Hôpital Paule de Viguier, Toulouse, France
| | - Gabriel Etienne
- Hematology Department, Institut Bergonié, Bordeaux, France; French Group of CML (Fi-LMC Group), Bordeaux, France
| |
Collapse
|
9
|
Rousset-Jablonski C, Giscard d'Estaing S, Bernier V, Lornage J, Thomas-Teinturier C, Aubier F, Faure-Conter C. [Gonadal function after treatment for a childhood or adolescent cancer]. Bull Cancer 2015; 102:602-11. [PMID: 25890827 DOI: 10.1016/j.bulcan.2015.03.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2015] [Accepted: 03/18/2015] [Indexed: 11/29/2022]
Abstract
Due to high cure rate in childhood and adolescent cancer, fertility preservation is a major concern. Chemotherapy, radiotherapy and surgery may alter gonadal function, and uterine cavity in women. In women, combined toxicity affecting both endocrine function and ovulation are observed leading to premature ovarian insufficiency. In men, spermatogenesis is frequently affected whereas endocrine function is almost always preserved. The current article focuses on investigations concerning gonadal function after treatment for a cancer during childhood or adolescence and treatment of subsequent infertility or hypogonadism. Nevertheless, those therapeutic are still limited and pretherapeutic preservation of fertility is preferred when possible.
Collapse
Affiliation(s)
| | - Sandrine Giscard d'Estaing
- Centre d'étude et de conservation des œufs et du sperme humain (CECOS), hôpital femme-mère-enfant, 69500 Bron, France
| | - Valérie Bernier
- Institut de cancérologie de Lorraine, département de radiothérapie, 54500 Vandœuvre-lès-Nancy, France
| | - Jacqueline Lornage
- Hôpital Femme-Mère-Enfant, service de médecine de la reproduction, 69500 Bron, France
| | - Cécile Thomas-Teinturier
- AP-HP, site de Bicêtre, service d'endocrinologie et de diabétologie pédiatrique, 94270 Le Kremlin-Bicêtre, France
| | | | - Cécile Faure-Conter
- Institut d'hématologie et d'oncologie pédiatrique (IHOP), département d'oncologie pédiatrique, 69008 Lyon, France.
| |
Collapse
|
10
|
Plotton I, Giscard d'Estaing S, Cuzin B, Brosse A, Benchaib M, Lornage J, Ecochard R, Dijoud F, Lejeune H. Preliminary results of a prospective study of testicular sperm extraction in young versus adult patients with nonmosaic 47,XXY Klinefelter syndrome. J Clin Endocrinol Metab 2015; 100:961-7. [PMID: 25423570 DOI: 10.1210/jc.2014-3083] [Citation(s) in RCA: 64] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
CONTEXT Testicular sperm extraction (TESE) in adult patients with nonmosaic 47,XXY provides a sperm retrieval rate (SRR) of approximately 50%. Age is the only significant prognostic factor. Whether TESE should be performed in adolescent patients for sperm cryopreservation remains to be determined. OBJECTIVE The objective of the study was to compare SRR between young (15-23 y) and adult (> 23 y) patients with 47,XXY, and to determine whether previous androgenic treatment had a deleterious effect. DESIGN We designed a prospective comparative study between two groups enrolled in parallel from September 2010 onward. SETTING University hospital. PATIENTS Forty one patients with nonmosaic 47,XXY karyotype and azoospermia were included. Twenty five patients from 15-22 years of age were assigned to the "Young" group, and 16 patients age 23 years or more, to the "Adult" group. INTERVENTION A bilateral testicular open biopsy was performed by a single surgeon. The reproductive biologist who performed TESE was blind to the patient's age. Principal Outcome Measure: The main outcome measure was the SRR. The TESE procedure was considered positive if at least 20 sperm cells could be cryopreserved for intracytoplasmic sperm injection. RESULTS SRR was 13/25 = 52% in the Young group and 10/16 = 62.5% in the Adult group, the difference being nonsignificant (P = .73). Ages were 24.3 ± 7.4 years in the 23 cases of positive TESE, and 23.7 ± 7.4 in the 18 cases of negative TESE, the difference being nonsignificant (P = .42). SRR was 9/17 = 52.9% for patients with and 14/24 = 59.1% for patients without previous testosterone (T) treatment, the difference being nonsignificant (P = .98). CONCLUSIONS According to the present results, performing TESE at a younger age (15-23 y) in patients with azoospermic nonmosaic 47,XXY Klinefelter did not increase SRR relative to adult patients (25-39 y). Previous replacement treatment with moderate doses of T did not seem to be deleterious for the recovery of sperm cells by TESE.
Collapse
Affiliation(s)
- Ingrid Plotton
- Service de Médecine de la Reproduction (I.P., S.G.d.E., A.B., M.B., J.L., H.L.), Hôpital Femme Mère Enfant, Laboratoire d'Hormonologie - Endocrinologie Moléculaire et Maladies Rares (I.P.) and Laboratoire d'Anatomopathologie (F.D.) Centre de Biologie et de Pathologie Est, Groupement Hospitalier Est; Service d'Urologie et de Transplantation (B.C.), Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, F-69003, France; Service de Biostatistique (R.E.) Hospices Civils de Lyon F-69000, Laboratoire Biostatistique Santé UMR CNRS 5558 (R.E.); Université Claude Bernard Lyon 1 (I.P., S.G.d.E., M.B., J.L., R.E., F.D., H.L.), Lyon F-69000, France; and INSERM U 846 (I.P., S.G.d.E., M.B., J.L., H.L.), Lyon, F-69000, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Daudin M, Rives N, Walschaerts M, Drouineaud V, Szerman E, Koscinski I, Eustache F, Saïas-Magnan J, Papaxanthos-Roche A, Cabry-Goubet R, Brugnon F, Le Lannou D, Barthélémy C, Rigot JM, Fréour T, Berthaut I, Giscard d'Estaing S, Touati F, Mélin-Blocquaux MC, Blagosklonov O, Thomas C, Benhamed M, Schmitt F, Kunstmann JM, Thonneau P, Bujan L. Sperm cryopreservation in adolescents and young adults with cancer: results of the French national sperm banking network (CECOS). Fertil Steril 2014; 103:478-86.e1. [PMID: 25527232 DOI: 10.1016/j.fertnstert.2014.11.012] [Citation(s) in RCA: 69] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2014] [Revised: 10/23/2014] [Accepted: 11/10/2014] [Indexed: 01/01/2023]
Abstract
OBJECTIVE To determine the feasibility of fertility preservation in adolescent males with cancer. DESIGN Large multicenter retrospective study of male patients ≤20 years from 23 centers of a national network of sperm banks over a 34-year period. SETTING Sperm banks. PATIENT(S) A total of 4,345 boys and young men aged 11 to 20 years. INTERVENTION(S) Age, cancer diagnosis, feasibility of sperm banking, and sperm parameters. MAIN OUTCOME MEASURE(S) Description of patients, and success of their fertility preservation. RESULT(S) We observed a mean yearly increase in referred patients of 9.5% (95% confidence interval, 9.1%-9.8%) between 1973 and 2007. Over the study period, the percentage of younger cancer patients who banked their sperm increased, especially in the 11-14 year age group, rising from 1% in 1986 to 9% in 2006. We found that 4,314 patients attempted to produce a semen sample, 4,004 succeeded, and sperm was banked for 3,616. The mean total sperm count was 61.75 × 10(6) for the 11-14 year age group, and 138.81 × 10(6) for the 18-20 year age group. It was noteworthy that intercenter variations in practices involving young patients seeking to preserve their fertility before cancer therapy were observed within this national network. CONCLUSION(S) Our results emphasize the need for decisive changes in public health policy to facilitate the access to reproductive health-care for young cancer patients.
Collapse
Affiliation(s)
- Myriam Daudin
- CECOS Midi-Pyrénées, University Hospital of Toulouse, Hôpital Paule de Viguier, Toulouse, France; Groupe de Recherche en Fertilité Humaine (EA 3694, Human Fertility Research Group), Université de Toulouse-UPS, Toulouse, France.
| | - Nathalie Rives
- CECOS Haute-Normandie, Reproductive Biology Laboratory and EA 4308 (Spermatogenesis and Male Gamete Quality), Rouen University Hospital, Rouen, France
| | - Marie Walschaerts
- Groupe de Recherche en Fertilité Humaine (EA 3694, Human Fertility Research Group), Université de Toulouse-UPS, Toulouse, France
| | - Véronique Drouineaud
- CECOS de Dijon, Reproductive Biology Laboratory, Centre Hospitalier Universitaire de Dijon, Dijon, France
| | - Ethel Szerman
- CECOS de Caen, Département de Biologie, Unité de Biologie de la Reproduction, CHU de Caen, Caen, France
| | - Isabelle Koscinski
- CECOS Alsace, Laboratoire de Biologie de la Reproduction, CHU de Strasbourg, Schiltigheim, and Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Institut National de Santé et de Recherche Médicale (INSERM) U964/Centre National de Recherche Scientifique (CNRS) UMR 1704/Université de Strasbourg, Strasbourg, France
| | - Florence Eustache
- CECOS-Service d'Histologie-Embryologie-Cytogénétique, Hôpital Jean Verdier (AP-HP), Bondy, France
| | - Jacqueline Saïas-Magnan
- CECOS de Marseille, Laboratoire de Biologie de la Reproduction, Hôpital de la Conception, AP-HM, Marseille, France
| | - Aline Papaxanthos-Roche
- CECOS Aquitaine, Service de Biologie de la Reproduction, CHU de Bordeaux, Université Bordeaux II, Maternité Pellegrin, Bordeaux, France
| | - Rosalie Cabry-Goubet
- CECOS Picardie, Cytogenetic and Reproductive Biology and Medicine Department, University Hospital of Amiens, and Unité INERIS EA 4285-UMI 01, UFR Médecine d'Amiens, Amiens, France
| | - Florence Brugnon
- CECOS Auvergne, Assistance Médicale à la Procréation, CHU Estaing, and Biologie de la Reproduction (EA 975), Université d'Auvergne, Clermont-Ferrand, France
| | - Dominique Le Lannou
- CECOS de l'Ouest, Unité Biologie de la Reproduction, CHU Rennes, Rennes, France
| | - Claire Barthélémy
- CECOS Région Centre-Ouest, Laboratoire de Biologie de la Reproduction, Centre Olympe de Gouges, CHU Bretonneau, Tours, France
| | - Jean-Marc Rigot
- CECOS Nord, Andrologie, Hôpital Calmette, CHRU de Lille, and EA 4308 Université Lille Nord, Lille, France
| | - Thomas Fréour
- CECOS de Nantes, Médecine et Biologie et Médecine de la Reproduction, CHU de Nantes, Nantes, France
| | - Isabelle Berthaut
- CECOS Paris-Tenon, Service d'Histologie-Biologie de la Reproduction, Hôpital Tenon (AP-HP), Paris, France
| | - Sandrine Giscard d'Estaing
- CECOS de Lyon, Service de Médecine de la Reproduction, Hôpital Femme Mère Enfant, Bron, and Université Claude Bernard, Biologie Humaine, Lyon, France
| | - Françoise Touati
- CECOS de Nancy, Biologie du Développement et de la Reproduction, CHU Nancy, Maternité Régionale, Nancy, France
| | - Marie-Claude Mélin-Blocquaux
- CECOS Champagne-Ardennes, Service de Génétique, Biologie de la Reproduction, CECOS, CHU Reims, Hôpital Maison Blanche, Reims, France
| | - Oxana Blagosklonov
- CECOS Franche-Comté-Bourgogne, Service de Génétique Biologique, Histologie, Biologie du Développement et de la Reproduction, CHU Besançon, and Sciences Médicales et Pharmaceutiques de Besançon, Université de Franche-Comté, Besançon, France
| | - Claire Thomas
- CECOS de Grenoble, Laboratoire d'Aide à la Procréation, CHU Grenoble, Hôpital Couple-Enfant, Grenoble, France
| | - Mohamed Benhamed
- CECOS de Nice, Hôpital Archet, CHU Nice, INSERM U895, Nice, France
| | - Françoise Schmitt
- CECOS Alsace, Laboratoire de Microbiologie, Centre Hospitalier de Mulhouse, Mulhouse, France
| | - Jean-Marie Kunstmann
- CECOS Paris-Cochin, Hôpital Cochin (AP-HP), Université Paris Descartes, Paris, France
| | - Patrick Thonneau
- Groupe de Recherche en Fertilité Humaine (EA 3694, Human Fertility Research Group), Université de Toulouse-UPS, Toulouse, France
| | - Louis Bujan
- CECOS Midi-Pyrénées, University Hospital of Toulouse, Hôpital Paule de Viguier, Toulouse, France; Groupe de Recherche en Fertilité Humaine (EA 3694, Human Fertility Research Group), Université de Toulouse-UPS, Toulouse, France
| |
Collapse
|
12
|
Laverdure N, d'Estaing SG, Marec-Berard P. [Semen cryopreservation in adolescent with cancer: at which age can it be proposed?]. Bull Cancer 2012; 99:935-941. [PMID: 23289135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
The increased incidence of tumors in children and adolescents (Lacour, 2010), as well as therapeutic advances in recent decades, have led to an increase of fertility disorders in young adult cancer survivors. In pubescent boys, the use of cryopreserved sperm and assisted reproductive technology (ART) is a validated preventive option. Currently, there is no consensus on the age at which the semen cryoconservation has to be proposed. There is a wide disparity of care among centers in France. Based on the observation of Nathan,11 years old, in whom semen cryopreservation was performed at his request, we analyze local practices and discuss the indications for cryopreservation of sperm in young teenagers with cancer treated by potentially sterilizing treatment.
Collapse
Affiliation(s)
- Noémie Laverdure
- Institut d'hématologie-oncologie pédiatrique, 1, place Joseph-Renaut 69008, Lyon, France
| | | | | |
Collapse
|
13
|
Giscard d'Estaing S, Perrin D, Lenoir GM, Guérin JF, Dante R. Upregulation of the BRCA1 gene in human germ cells and in preimplantation embryos. Fertil Steril 2005; 84:785-8. [PMID: 16169426 DOI: 10.1016/j.fertnstert.2005.02.037] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2004] [Revised: 02/23/2005] [Accepted: 02/23/2005] [Indexed: 10/25/2022]
Abstract
The quantification of BRCA1 messenger RNA molecules by a quantitative competitive one-step reverse transcriptase polymerase chain reaction method indicates that BRCA1 is upregulated both in human male and female germ cells and in preimplantation embryos. Because BRCA1 is involved in several pathways that participate in preserving intact chromosome and genome integrity, these data suggest that BRCA1 dysfunction might alter human embryogenesis or fertility.
Collapse
|
14
|
d'Estaing SG, Lornage J, Hadj S, Boulieu D, Salle B, Guérin JF. Comparison of two blastocyst culture systems: coculture on Vero cells and sequential media. Fertil Steril 2001; 76:1032-5. [PMID: 11704129 DOI: 10.1016/s0015-0282(01)02737-6] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
OBJECTIVE To compare two blastocyst culture systems: culture on Vero cells and sequential media in the same time period. DESIGN Retrospective study. SETTING Institutional practice assisted reproductive technology center. PATIENT(S) Ninety-nine selected patients undergoing IVF with blastocyst culture. INTERVENTION(S) In vitro fertilization and transfer of at least one expanded blastocyst after culture using either Vero cells or sequential media (S(2) medium). MAIN OUTCOME MEASURE(S) Blastocyst, pregnancy, and implantation rates. RESULT(S) The blastocyst formation rate (41.6% vs. 31.6%) is significantly increased with sequential media compared with the coculture system, but there is no statistically significant difference in the pregnancy and implantation rates (39.5% vs. 38.6% and 23.7% vs. 15.1%, respectively). CONCLUSION(S) Blastocyst culture on sequential media offers a better dynamic of embryo development (22% vs. 13.6% blastocyst at day 5). There was no statistically significant difference between the two groups in the take-home baby rate (18 vs. 12).
Collapse
Affiliation(s)
- S G d'Estaing
- Département de Médecine de la Reproduction, Centre hospitalier de l'Université de Biologie de la reproduction, Hôpital Edouard Herriot, Lyon, France.
| | | | | | | | | | | |
Collapse
|